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Abstract
Polycomb Repressive Complex 2 (PRC2) methylates histone H3 tails at lysine 27 and is essential
for embryonic development. The three core components of PRC2, Eed, Ezh2, and Suz12, are also
highly expressed in embryonic stem (ES) cells where they are postulated to repress developmental
regulators and thereby prevent differentiation to maintain the pluripotent state. We performed gene
expression and chimera analyses on low and high passage Eednull ES cells to determine whether
PRC2 is required for the maintenance of pluripotency. We report here that, although developmental
regulators are overexpressed in Eednull ES cells, both low and high passage cells are functionally
pluripotent. We hypothesize that they are pluripotent because they maintain expression of critical
pluripotency factors. Given that EED is required for stability of EZH2, the catalytic subunit of the
complex, these data suggest that PRC2 is not necessary for the maintenance of the pluripotent state
in ES cells. We propose a positive-only model of embryonic stem cell maintenance, where positive
regulation of pluripotency factors is sufficient to mediate stem cell pluripotency.
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Introduction
One of the earliest and most dynamic mechanisms of epigenetic gene regulation is covalent
modification of histone tails by the Polycomb Repressive Complex 2 (PRC2). PRC2 is
comprised of three core components, EED, EZH2, and SUZ12. EZH2 is a histone
methyltransferase and the catalytic subunit of the PRC2 complex. While the functions of EED
and SUZ12 remain unknown, all three core components are minimally required for robust
PRC2 activity1. EED, however, is required for the stability of the EZH2 and SUZ12 proteins
and global H3K27 methylation2.
PRC2 methylates histone H3 at lysine 27 (H3K27). Trimethylated H3K27 (H3K27me3)
recruits Polycomb Repressive Complex 1 (PRC1)3, which in turn mediates chromatin
condensation4, and may even recruit DNA methyltransferases5 to specific genes during
development. This process leads to transcriptional silencing and inheritance of the silenced
state to daughter cells6, 7. PRC2, through this heritable mechanism of epigenetic gene
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repression, functions in the maintenance of cellular identity in hematopoietic stem cells8, 9,
differentiating trophoblast cells10, embryonic mesoderm11, and cancer stem cells12, 13.
Reports also implicate PRC2 in the maintenance of the pluripotent state in embryonic stem
cells14-17.
PRC2 binds to and represses the transcription of many developmental regulators that are
markers of differentiated cell lineages in both mouse and human ES cells15, 16, 18.
Additionally, H3K27me3 colocalizes with histone H3 lysine 4 trimethylation (H3K4me3), a
chromatin modification associated with active genes, in bivalent domains at several promoters
that mark genes that are silenced but poised for activation15, 19, 20. Remarkably, about 50%
of bivalent domains coincide with binding sites for OCT4, NANOG, or SOX2, transcription
factors required for maintaining pluripotency in ES cells. OCT4 itself, was recently shown to
bind to and activate the EED promoter in mouse ES cells17. These data point to an attractive
hypothesis where ES cell identity is maintained by a careful balance between PRC2-mediated
silencing and gene expression mediated by the transcription factors, OCT4, NANOG, and
SOX2.
We wanted to determine whether PRC2 was required to maintain ES cell identity and the
pluripotent state by comparing gene expression and functional measures of pluripotency in low
and high passage Eednull ES cells. We report here that, although developmental regulators are
overexpressed in Eednull ES cells, both low and high passage cells are functionally pluripotent.
We hypothesize that they are pluripotent because they maintain expression of critical
pluripotency factors and do not respond to differentiation signals. These data suggest that
PRC2, and perhaps epigenetic silencing, is not necessary for maintaining the pluripotent state
in embryonic stem cells. Rather, PRC2 may be important for transitions in cell fate
(differentiation) and maintenance of multipotency in later progenitor cells. We propose a
positive-only model of embryonic stem-cell maintenance, where positive regulation of
pluripotency factors is sufficient to mediate stem cell pluripotency.
Materials and Methods
ES cells and culture
Eednull ES cell lines and their wild-type sibling ES lines were derived from the
Eed17Rn53354SB strain of mice carrying the ROSA26 β-geo transgene21. These ES cells carry
a homozygous point mutation in the Eed gene that results in a functionally null allele22, as
well as a constitutively expressed β-geo gene that serves as a reporter and a selectable marker.
Images and a detailed description of mutant ES cell morphology can be found in Figure S1.
Eednull ES cells were maintained on irradiated murine embryonic fibroblasts (MEFs) using
standard ES culture conditions. Specifically, cells were grown in ES media, consisting of
MEM-α (Invitrogen) medium with 15% fetal calf serum (Invitrogen) supplemented with non-
essential amino acids, glutamate, sodium pyruvate, β-mercaptoethanol, pen-strep, and LIF.
MEF conditioned media was also produced by growing irradiated MEFs in ES media for 48
hours and collecting the media. To generate RNA, ES cells were passaged onto a gelatinized
plate and cultured with 50% MEF-conditioned media/50% ES media.
To generate high pass ES cells, both Eednull and wild-type ES cells were cultured for 25
additional passages. Low pass refers to ES cells at pass 7 (p7), while high pass refers to ES
cells at pass 32 (p32) or higher. Eednull ES cells can be maintained with good morphology (Fig.
S1). All ES lines used in this study were feeder and LIF dependent. For microarray analysis,
p32 cells were used and for chimera analysis, p35 cells were used for high pass cultures.
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ES cells were cultured on gelatin-coated coverslips with feeders as described above. Coverslips
were treated with CSK buffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, and 10 mM
PIPES [pH 6.8]) containing 0.5% Triton-X, fixed in 4% paraformaldehyde/1X PBS, and stored
in 70% ethanol. Coverslips were washed in 1× PBS and incubated in a humid chamber with
blocking buffer (1× PBS, 5% goat serum, 0.2% Tween-20, and 0.2% fish skin gelatin). Blocked
samples were incubated with primary antibodies (anti-1mH3K27 [Upstate], anti-2mH3K27
[Upstate], anti-3mH3K27[Upstate], anti-OCT4[Santa Cruz], anti-NANOG[Santa Cruz])
diluted 1:200 in blocking buffer. The coverslips were then washed in 1× PBS/0.2% Tween-20,
blocked again in blocking buffer, and incubated with the appropriate secondary antibody (Goat
anti-Rabbit Alexa 594, Goat anti-Rabbit Alexa 488, Goat anti-Mouse Alexa 594, or Goat anti-
Mouse Alexa 488 [Molecular Probes]). Coverslips were washed in 1× PBS/0.2% Tween-20
and mounted with Vectashield (Vector Laboratories). Stained slides were visualized by
fluorescence microscopy.
Microarray analysis
Eednull and wild-type ES cells were cultured in triplicate for microarray analysis. Samples were
harvested and RNA was isolated using Trizol reagent (Invitrogen) according to the
manufacturer's instructions. RNA was further purified using RNeasy columns (QIAGEN). The
quality of the RNA was confirmed prior to labeling using the Agilent Nano RNA Lab-on-a-
Chip and the 2100 Bioanalyzer.
RNAs were combined with RNA spike-in control RNAs from the RNA Spike-In kit (two color,
Agilent) and labeled using the RNA Low-Input Linear Amp Kit PLUS (two color, Agilent)
with Cyanine 3-CTP (NEN) and Cyanine 5-CTP (NEN) dyes. The labeled RNAs were again
purified using RNeasy columns (QIAGEN). Quality and labeling fidelity of the labeled RNAs
was assessed using the Nano RNA Lab-on -a-Chip and the 2100 Bioanalyzer (Agilent).
The following head-to-head experiments were performed using both dye directions (Cy3 vs
Cy5 and then swapped). Low pass mutant versus low pass wild-type and high pass mutant
versus high pass wild-type for each of the three replicates. In total, 12 microarrays were
completed. Labeled RNAs were hybridized to the 4X44K mouse whole genome oligo
microarray for at least 17 hours in Hi-RPM hybridization buffer (Agilent), according to
manufacturer's protocols. Microarray slides were washed according to manufacturer's
instructions and scanned on an Agilent microarray scanner. The microarray images were
interpreted using Feature Extraction 9.5 software and further normalized using GeneSpring
GX software. Default normalizations were performed that included Lowess normalization and
dye swap transformation on appropriate arrays. Data were averaged only for the 3 replicates
for any one dye direction. The dye swaps verified that the data did not suffer from dye bias.
Interpretation of microarray data
To identify genes overexpressed in Eednull ES cells, GeneSpring GX was used to sort genes
in which the expression level of mutant relative to wild-type ES cells was greater than 2.0 in
at least 6 of 12 instances. This would take into account both low and high pass comparisons,
but assure that the results were technically repeatable. Correlation of H3K27me3 bound genes
and overexpressed genes was determined by merging the list of overexpressed genes with the
chromatin structure status of the promoters included in the supplementary data from Mikkelsen
et al20.
Graphs comparing expression levels for developmental regulators and pluripotency genes were
performed from the average of 3 technical replicates. All unique transcripts representing
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individual genes were included in the analysis. The data were plotted using the graph function
of Excel. Error bars shown represent the standard error from the three technical replicates.
Real-time RT-PCR
Samples were prepared for real-time RT-PCR by pooling 3 wells each of low pass wild-type,
high pass wild-type, low pass Eednull, and high pass Eednull ES cells, and harvesting RNA
using Trizol reagent (Invitrogen). RNAs were purified using RNeasy columns (QIAGEN).
Two samples from each condition were provided for RT-PCR analysis. Real time RT-PCR
was carried out on the RNA samples by Dr. Hyung-suk Kim in the Animal Clinical Chemistry
and Gene Expression Facility at the University of North Carolina at Chapel Hill using Taqman
technology (Applied Biosystems).
Generation and analysis of chimeras
Chimeric embryos were generated by the Animal Models Core at the University of North
Carolina at Chapel Hill. We provided the core facility with either low pass or high pass ES
cells that were grown on a MEF feeder layer for 48 hours and harvested by trypsinization. The
Animal Models Core performed blastocyst injections using standard procedures. Pregnant
females were dissected at 9.5, 10.5, or 12.5 dpc, where the date of blastocyst injection was
considered as 3.5 dpc. Embryos were dissected in 1X PBS and fixed with 0.2% glutaraldehyde.
Embryos were processed for XGal staining with ferric salts. Stained embryos were rinsed 3
times in 1× PBS, postfixed in 4% paraformaldehyde, and cleared using a glycerol gradient.
Following photography, embryos were embedded in paraffin or OCT for sectioning. Embryos
prepared for paraffin sections were dehydrated through an ethanol gradient and incubated with
xylenes and permeating paraffin prior to embedding in paraffin. Paraffin embedded embryos
were sectioned at 8 μM, deparaffinized, and counterstained with nuclear fast red before
dehydration and mounting. Embryos prepared for frozen sections were cryoprotected using a
sucrose gradient and OCT prior to embedding in OCT and freezing. Cryosections were 10
μM and were not counterstained prior to dehydration and mounting.
Results
Eednull ES cells retain H3K27 monomethylation
Our previous observation that Eednull ES cells lacked H3K27me1, me2, and me3 pertained to
high passage Eednull ES cells2. We repeated the immunocytochemistry using antibodies
specific for each of the three forms of H3K27 methylation on low and high passage Eednull ES
cells to confirm this observation. Surprisingly, we found that H3K27me1 was readily detectable
in low passage Eednull ES cells but not in high passage mutant ES cell lines (Fig. 1A & B).
Figure 1A shows wild-type along with low and high pass Eed mutant ES cells stained with an
antibody against H3K27me1. The loss of H3K27me1 was observed in two independent high
passage Eednull ES cell lines (data not shown), as well as cells newly passaged for these
experiments, indicating that loss of H3K27me1 was not an artifact of clonal variation. Figure
1B shows Eednull ES cells at a low passage number, stained with polyclonal antibodies against
H3K27me1, 2me, and 3me. DAPI stains in the right panel identify the ES cell colony. Both
low and high passage Eednull ES cells lack H3K27me2 and me3, consistent with previous
reports.
Promoters of genes overexpressed in Eednull ES cells are bound by PRC2
Boyer et al. observed spontaneous differentiation in cultures of high pass Eednull ES cells18,
supporting their hypothesis that ES cell identity is maintained, in part, by PRC2-mediated gene
repression. Although we do not observe spontaneous differentiation using the same Eednull ES
cells, we nonetheless wondered whether the presence of H3K27me1 in low passage Eednull ES
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cells supports self-renewal of pluripotent ES, and whether pluripotency is lost concurrent with
loss of H3K27me1 in high passage cell lines. We used microarray expression analyses to assess
changes in gene expression between low and high passage Eednull ES cells. We performed
head-to-head expression experiments between low and high passage Eednull ES cells using
passage-matched wild-type ES cells as controls. We assayed 41,267 unique transcripts, and
found that 351 transcripts were upregulated more than 2-fold in high passage Eednull ES cells
over low passage mutant ES cells. This number compares to the 295 transcripts that were
upregulated more than 2-fold between high passage and low passage wild-type controls. These
data suggest that the absence of H3K27me1 plays a minor role in global gene expression in
Eed mutant ES cells.
PRC2 is purported to maintain pluripotency through repression of developmental regulators
16, 18, 23, 24. We wondered whether we could detect previously observed changes in gene
expression between mutant and wild-type Eednull ES cells. We used microarray expression
analysis to directly compare passage-matched Eednull and wild-type ES cells. We compared
low passage mutant and wild-type ES cells, as well as high passage mutant and wild-type ES
cells. In all, 2,037 transcripts, or 4.9% of the transcripts represented on the microarray, were
determined to be upregulated by 2-fold or more in low and/or high pass Eednull ES cells. Only
106 of the 2,037 genes were overexpressed in high passage versus low passage Eednull ES
cells, reinforcing the lack of large-scale differences between low and high pass mutant ES cells.
Data using single molecule-based sequencing technology for profiling histone modifications
identified promoters containing H3K27me3, either alone or in a bivalent domain with the
H3K4me3 modification in mouse ES, neural precursor (NPC), or embryonic fibroblast (MEF)
cells20. We correlated our expression data with these histone modification profiles, and found
that 27% of the promoters modified with H3K27me3 or the bivalent marks in ES cells were
upregulated by 2-fold or more in Eednull ES cells. Transcription factors required for the
expression of some H3K27me3 bound genes may not be present in ES cells, and may explain
why all PRC2 bound promoters are not activated in Eed mutant ES cells. Only 6% of promoters
containing H3K27me3 alone are upregulated in Eednull ES cells, suggesting that an activating
chromatin modification is largely required for expression of PRC2 silenced genes. These data
are summarized in Table S1.
Of the 2,037 transcripts overexpressed in Eednull ES cells, 747 transcripts, representing almost
37% of all overexpressed transcripts, harbor bivalent promoters in ES cells. When we
considered the histone modification profiles of the upregulated genes in lineage-committed
cells, we found that 3% and 16% of upregulated genes were marked by bivalent promoters in
NPCs and MEFs, respectively. These data are summarized in Table S2. All overexpressed
transcripts are not marked with H3K27me3, suggesting that many transcripts overexpressed
in Eednull ES cells are not directly regulated by PRC2 and may be secondary effects.
We then identified developmental regulators that were previously shown to be marked by
H3K27me3 and upregulated by real-time PCR18 in our microarray data. Consistent with
previous results, Gata genes that are Polycomb bound (Gata3, Gata4, and Gata6) were
upregulated in mutant ES cells, but genes not bound by Polycomb (Gata1 and Hprt) had
expression levels similar to wild-type ES cells (Fig. 2A). Three unique Gata6 transcripts were
represented on the microarray. Interestingly, one of these is not upregulated in mutant ES cells,
suggesting that the particular splice form may be regulated by tissue- or developmental stage-
specific splicing that does not occur in ES cells. Many other Polycomb-bound developmental
regulators were also found to be upregulated in Eednull ES cells (Fig. 2 B,C). Additionally, we
found that expression levels of these genes were lower in low pass ES cells (Fig. 2B), and
higher in high pass ES cells (Fig. 2C). These data support the previous finding that PRC2 is
required for the repression of important developmental regulators in ES cells.
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Expression of pluripotency genes in Eednull ES cells
Pluripotency is partly determined by positive regulation of a transcriptional program of
expression conducive to maintaining the pluripotent state. The transcription factors, OCT4,
SOX2, or NANOG are required to maintain the pluripotent state. Embryos lacking these
proteins fail to maintain an inner cell mass, and ES cells lacking these factors cannot be
derived25-27.
We assessed expression levels of previously known pluripotency factors in low and high
passage Eednull ES cells to determine whether they are expressed in mutant ES cells. Figure
3A shows the microarray expression levels of known pluripotency factors in low and high pass
Eednull ES cells relative to wild-type, passage-matched counterparts. Real-time PCR was used
to verify the expression levels of some of these genes (Fig. 3B). We also analyzed protein
expression using immunocytochemistry for OCT4 and NANOG (Fig. 3C). Most of the known
pluripotency factors show reduced expression in mutant ES cells compared to wild-type ES
cells (Fig. 3A & B), however, only Sox2, Zfp42, and Oct4 in high passage cells are expressed
at levels less than 50% of wild-type levels, denoted by the dotted line. ES cells were cultured
for 48 hours off of feeder cells prior to collecting RNA. Since Eednull ES cells are feeder
dependent, reduced levels of pluripotency factors may reflect early differentiation resulting
from feeder free culture conditions. Supporting this notion, immunocytochemistry for OCT4
on cells maintained on feeders showed intense staining in mutant ES cells, similar to their wild-
type counterparts.
Many of the pluripotency proteins mentioned above are transcription factors whose down-
stream targets are the real effectors of self-renewal. Expression profiles of murine ES cells
have been correlated with functional measures of pluripotency, such as the ability to form all
germ layers in embryoid bodies and the ability to contribute to chimeric animals, to identify
genes that mediate self-renewal28. We identified these genes in our microarray data (Figure
4A). Real-time PCR verification of data from fourz of the genes is shown in Figure 4B.
Eednull ES cells maintain expression levels that are greater than or equal to expression levels
in wild-type ES cells for most of the genes assayed. Wild-type expression levels are indicated
by a relative expression level of 1.0, and are depicted by a black line. For most transcripts, low
pass Eednull ES cells show higher expression levels than high pass mutant ES cells, however,
high pass mutant ES cells maintain expression at wild-type levels or higher for most genes.
These data suggest that although pluripotency-related transcription factors have reduced
expression in Eednull ES cells, the expression profile of downstream genes that actually
correlate with functional measures of pluripotency are not reduced.
Eednull ES cells contribute to chimeras
The most stringent test of pluripotency for murine ES cells is whether the ES cells can
contribute to all tissue lineages in chimeric embryos. Previously, we had published that
Eednull ES cells could contribute to all lineages in embryoid bodies as well as chimeric
embryos21. These experiments were completed using ES cells at an early passage number (p5).
To determine whether EED and H3K27 methylation is required for the maintenance of the
pluripotent state, we repeated chimera analysis using low and high pass Eednull ES cells. Low
pass (p7) or high pass (p34) Eednull ES cells were injected into 3.5 dpc wild-type blastocysts.
Chimeric embryos were dissected 6, 7, or 10 days after blastocyst injection (equivalent to 9.5,
10.5, or 12.5 dpc) and were fixed and stained for β-galactosidase activity. Eednull ES cells carry
a β-geo cassette at the Rosa26 locus, allowing mutant cells to be tracked because of their blue
color upon staining. Both low and high passage Eednull ES cells were able to contribute to all
tissues in chimeric embryos. Table 1 summarizes results from blastocyst injections.
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High contribution chimeras were obtained with both sets of Eednull ES cells. From early pass
ES cells, 4 embryos had at least 50% Eednull ES cell contribution. From late pass ES cells at
9.5 dpc, 8 embryos had at least 50% Eednull ES cell contribution. Figure 5A-C, and 5G and H,
show representative high or moderate contribution chimeric embryos from low pass and high
pass mutant cells, respectively. Eednull cells could be found in all tissues. Figure 5D-F, depicts
histological sections from low pass chimeric embryos. Arrow, asterisk, and dashed arrow
indicate ES cell contribution to neurectoderm, mesoderm, and gut endoderm tissues,
respectively. Figure 5I-L, represents histological sections from high pass Eednull chimeras.
Arrows, asterisks, and dashed arrows, indicate ectoderm, mesoderm, and endoderm
derivatives, respectively. It is worth noting, as described previously21, high contribution
chimeras produced with Eednull ES cells display some of the same defects as homozygous
mutant embryos (Fig.5G & J). These defects include an overabundance of allantois (boxed
area; Fig. 5J), a poorly developed neurectoderm (arrow; Fig. 5J), and paucity of embryonic
mesoderm (asterisk, Fig. 5J). These defects are likely to cause embryonic lethality around 10.5
dpc in the highest contribution chimeras. Moderate chimeras develop normally, and Eednull
cells appear morphologically normal in surface epithelia (open arrow; Fig. 5L), neurectoderm
(arrow; Fig. 5I), and embryonic blood (Fig 5K). By the most stringent measures, both early
and late passage Eednull ES cells are indeed pluripotent.
Lethality of differentiated Eednull cells
Despite robust participation by Eednull cells in 9.5 dpc chimeric embryos, Eednull cells are
scarce in 12.5 dpc embryos. In later stage chimeric embryos, Eednull cells appear to be limited
to a few neurons (arrows, Fig. S3) and embryonic blood cells (asterisk, Fig. S3), occurring
only in a few embryos. Reduced numbers of 12.5 dpc embryos were recovered from blastocyst
injections, and many of those embryos were defective. We suspect that the lack of embryos
and the defects observed may be due to the death of high contribution chimeric embryos and
to the loss of differentiated Eednull cells that were previously contributing to moderate or low
contribution chimeric embryos.
To determine whether terminally differentiated Eednull cells were capable of survival, we
isolated mouse embryonic fibroblasts (MEFs) from 10.5 dpc chimeric embryos. We chose this
stage because it preceded the wave of lethality of high to moderate contribution chimeras, but
produced larger embryos with more cells. Whole 10.5 dpc embryos were dissociated by passage
through a needle and plated. Eednull cells can be selected for using G418 because the mutant
ES cells contain a β-geo cassette at the Rosa26 locus, which confers resistance to G418.
Twenty-four hours after plating, G418 was added to some of the MEFs in culture. Although
wild-type MEFs could be recovered from embryos without selection, Eednull MEFs were not
recovered from dissociated embryos plated with or without G418. In some cases, poor cellular
growth occurred from plated embryos, even in the absence of G418. In these cases, few cells
attached to the tissue culture dish, and they failed to divide further. One similar MEF outgrowth
was stained for β-galactosidase activity, and positive staining confirmed that the cells were
Eednull. A few (4 total) LacZ positive cells were also seen in a robustly growing MEF culture
without G418 selection, 4 days after initial plating. However, upon splitting this culture
Eednull (LacZ positive) cells could not be found. These data suggest that Eednull MEFs cannot
be maintained in culture.
Discussion
Previous studies demonstrated a role for PRC2 and H3K27me3 in the repression of
developmental regulators15, 16, 18, 24. Boyer et al. extended this observation to suggest that
PRC2 was required for maintenance of the pluripotent state because Eednull ES cells aberrantly
express lineage-specific markers and spontaneously differentiate in culture16, 18. However,
Chamberlain et al. Page 7













the same Eednull ES cells were previously shown to contribute to all tissue lineages in embryoid
bodies and chimeric embryos, and are therefore functionally pluripotent21. These disparate
results were obtained with high passage and low passage Eednull ES cells, respectively. We
hypothesized that high passage Eednull ES cells were not pluripotent, and that differences
between low and high passage ES cells would reveal the factors responsible for the loss of
pluripotency.
Since previously published characterization of H3K27 methylation in Eednull ES cells was
carried out on high passage cells, we first wanted to verify that low passage mutant ES cells
lacked global H3K27 methylation. Previous data suggested that H3K27me1 may be mediated
by a complex other than the canonical PRC2 complex and that EED is also a member of the
alternate complex2, 29 (S. Chamberlain and T. Magnuson, unpublished data). To our surprise,
low passage Eednull ES cells retained H3K27me1, while high passage mutant cell lines lacked
this modification. H3K27me2 and me3 are found at the promoters of genes silenced by PRC2,
but the function of H3K27me1 is poorly understood. H3K27me1 is thought to be a dynamic
modification that is widely distributed across euchromatin, except for the transcriptional start
sites of active genes30. We speculate that EED likely mediates monomethylation since it is
absent in high passage mutant ES cells. However, the removal of H3K27me1 may occur
passively, as opposed to H3K27me3, which can be actively removed by the histone
demethylases UTX and JMJD3. Upon comparing cellular morphology and expression profiles
of low passage and high passage Eednull ES cells, we found few changes, suggesting that global
expression changes do not result from the loss of H3K27 monomethylation.
The changes in expression between Eednull ES cells and passage-matched wild-type ES cells
that we observed agreed with previously published reports15, 18, 23 that demonstrated
increased expression levels of developmental regulators in Eednull ES cells. Ectopic expression
of lineage-specific genes was observed in both low and high passage Eed mutant ES cells.
Expression levels of many genes became further increased in high passage mutant ES cells.
These data support a role for PRC2 in the repression of developmental regulators.
Ectopic expression of developmental regulators can drive in vitro differentiation of ES cells.
For instance, forced expression of Gata4 and Gata6 directs ES cell differentiation to primitive
endoderm31, and overexpression of Cdx2 is sufficient to differentiate ES cells to
trophectoderm32, 33. Differentiation induced by overexpression of Cdx2, Gata4 and Gata6
was reinforced by downregulation of Oct4 and Nanog. Furthermore, depletion of OCT4,
NANOG, or SOX2 alone can result in the functional loss of pluripotency in embryos and ES
cells25-27, 34, 35. Expression levels of Oct4, Nanog, and Sox2 were reduced in Eednull ES
cells, however, mutant ES cells retained expression of the pluripotency-associated transcription
factors. Reduced expression levels of Oct4, Nanog and Sox2 may reflect early differentiation
due to the brief feeder-free culture condition. Robust staining for OCT4 and NANOG proteins
in Eednull ES cells maintained on feeders supports this possibility.
We also considered genes that were downregulated during the first 18 hours of differentiation
by LIF removal28. The reduced expression of these genes most closely correlated with loss of
functional pluripotency, suggesting that they were the downstream mediators of the pluripotent
state. Many of these factors have promoters that are themselves bound by OCT4, NANOG, or
SOX2 in mouse35 or human ES cells36, and thus are likely to represent part of the same
transcriptional network. Eednull ES cells retain expression of these pluripotency markers.
Additionally, low passage Eed mutant ES cells had higher expression levels than wild-type ES
cells. Although transcription factors known to mediate pluripotency are reduced in Eednull ES
cells, genes most closely correlated with functional pluripotency are not. This could occur
because the level of transcription of pluripotency-associated transcription factors, although
reduced, is sufficient to direct proper expression of downstream markers. Interestingly, recently
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reported induced pluripotent cell lines also show severely reduced levels of Oct4 and Sox2, but
are functionally pluripotent37.
Eednull ES cells were previously shown to be pluripotent by their ability to form three germ
layers and differentiate in vitro into various tissue types, including neurons, in embryoid bodies,
and by incorporation into most tissues of chimeric embryos21. Furthermore, primordial germ
cells are also specified in Eednull embryos, suggesting that mutant cells can even contribute to
the germline11. While these experiments were performed with the earliest passages of
Eednull ES cells, we have demonstrated here that both low and high passage Eednull ES cells
are pluripotent by chimeric embryo analyses, the most stringent test of pluripotency for mouse
ES cells.
Neurons can be generated from in vitro differentiation of Eednull ES cells21 but MEFs cannot.
Consistent with this finding, high contribution Eednull chimeras have a paucity of mesoderm,
but form neurectoderm. This suggests that although EED is dispensable for the maintenance
of a pluripotent stem cell population, it is still required for differentiation and/or maintenance
of multipotent progenitors. Interestingly, very few of the genes that are upregulated in
Eednull ES cells are marked with bivalent chromatin modifications in NPCs compared to
MEFs20. The bivalent modifications mark promoters that are silenced, but poised for
expression in that cell type19. The overexpression of genes that are required to be repressed
in MEFs may explain why we cannot derive that cell type from chimeric embryos. Conversely,
few of the overexpressed genes are required to be silenced in NPCs, in agreement with the
relatively normal development of neural precursor cells in embryoid bodies.
SUZ12-deficient ES cells have also been derived, and although it is not known whether they
are pluripotent, they can be maintained in culture and stain positively for OCT4 and NANOG
38. In contrast to EED-deficient ES cells, SUZ12-deficient ES cells cannot form neurons after
in vitro differentiation. While it is formally possible that a function for SUZ12 outside of the
canonical PRC2 complex could explain the disparate results, we think that this is unlikely
because SUZ12 protein is absent from EED-deficient ES cells2. One possible explanation is
that the retinoic acid (RA)-induced differentiation scheme used by Pasini et al. induced PRC2-
regulated genes that otherwise remained repressed in the EED-deficient embryoid bodies that
were not differentiated using RA. A recent report demonstrates that RA directly induces
expression of the JMJD3 histone demethylase, suggesting that RA induces activation of PRC2-
regulated genes via JMJD339. A better understanding of the interplay between PRC2 and its
corresponding histone demethylases during transcriptional activation is needed to fully
understand this dilemma. In any case, SUZ12-and EED-deficient ES cells each maintain
expression of key pluripotency factors while simultaneously expressing known differentiation
factors. This creates a situation where factors both positively and negatively influencing stem
cell self-renewal co-exist.
A minimal set of pluripotency factors may promote the necessary gene expression and cell
proliferation that is required to support stem cell self-renewal. The forced co-expression of 4
transcription factors, Oct4, Sox2, Klf4, and Myc can reprogram terminally differentiated
fibroblasts into pluripotent ES-like cells that contribute to the germline37, 40, 41. OCT4,
SOX2, and KLF4 function as transcription factors or co-activators26, 42, 43, while MYC
promotes the G1 to S phase transition44. While OCT4 may mediate gene repression by binding
and activating the Eed promoter17, we have demonstrated that that gene repression mediated
by EED is not necessary for the maintenance of pluripotent ES cells.
To our knowledge, no known epigenetic repressor is required for the maintenance of
pluripotency. In fact, a histone lysine demethylase that reverses a repressive histone
modification is essential for pluripotency45. We propose a positive-only model for the
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maintenance of pluripotency in ES cells (Figure 6). Expression of pluripotency factors or their
downstream targets may be sufficient to sustain self-renewal of pluripotent embryonic stem
cells, even when lineage-specific factors are aberrantly expressed. The notion that epigenetic
repression is dispensable for embryonic stem cell self-renewal is further supported by
observations that ES cells maintain an open chromatin conformation15, 46, 47 and transcribe
a large number of genes48, 49 50, 51. These data support the hypothesis that pluripotency is
the default state for genetic systems45, 52.
Conclusions
Our findings challenge the idea that PRC2 is necessary for the maintenance of pluripotent stem
cells.. We found that ES cells lacking PRC2 and H3K27 methylation are functionally
pluripotent. This observation has important implications in the understanding of embryonic
stem cell biology. First, although PRC2 is important in early embryo development, it is not
required to maintain the pluripotent stem cell population. Secondly, maintainted pluripotency
of PRC2-deficient ES cells in the presence of aberrantly expressed differentiation factors
implies that repression of differentiation is also not required for the maintenance of pluripotent
stem cells. Thus, the repressive activity of PRC2 on developmental regulators, while ultimately
detrimental to the survival of differentiated cells, is dispensable for maintaining pluripotency
in embryonic stem cells.
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Figure 1. H3K27 methylation in low pass Eednull ES cells
(A.)Wild-type, low pass Eednull, and high pass Eednull ES cells were stained with an antibody
against H3K27me1. Monomethylation is robust in wild-type ES cells and detectable in low
pass Eednull ES cells, but absent in high pass mutant ES cells. (B.) Low pass Eednull ES cells
were stained with antibodies against H3K27me1, me2, and me3. Low pass mutant ES cells
stain positively for H3K27me1, but not for H3K27me2 or me3. Positively staining feeder cells
serve as internal controls. Corresponding gray-scale images of DAPI stains are shown to the
right.
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Figure 2. Developmental regulators are aberrantly expressed in Eednull ES cells
Multiple listings for the same gene indicate independent transcripts represented on the
microarray, and may represent alternate splice forms. A horizontal black line on each graph
indicates a value of 1, indicating that mutant and wild-type ES cells have the same expression
levels. Error bars indicate standard error calculated from 3 technical replicates. (A.) Microarray
data reveals that Polycomb-bound Gata genes (Gata3, Gata4, and Gata6) show increased
expression in Eednull ES cells. Gata1 and Hprt, which are not Polycomb bound are shown as
controls. Gray bars represent low pass and black bars represent high pass Eednull ES cells. (B.)
Microarray data from low pass Eednull ES cells show an increase in expression compared to
wild-type ES cells for many Polycomb bound developmental regulators. These genes were also
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surveyed by Boyer et al18. (C.) Microarray data from high pass Eednull ES cells shows a further
increase in expression levels for the same genes shown in B.
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Figure 3. Expression of pluripotency factors in Eednull ES cells
Multiple listings for the same gene indicate independent transcripts represented on the
microarray and may represent alternate splice forms. Horizontal black lines indicate a value
of 1, where mutant and wild-type ES cells have the same expression levels. Dashed black lines
represent a value of 0.5, where mutant cells have half of the expression level as wild-type
counterparts. (A.) The relative expression levels of several pluripotency markers in low (gray
bars) and high (black bars) pass Eednull ES cells was determined by microarray analysis. While
most factors have lower expression levels than wild-type ES cells, gene expression is
maintained. With the exception of Klf4, low and high pass mutant cells have similar expression
levels. Error bars indicate standard error calculated from 3 technical replicates. (B.) Real-time
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RT-PCR verification of selected genes represented in panel A shows that expression levels are
reproducible. Real-time RT-PCR was carried out in duplicate on RNA generated from pooled
cell samples (3 different samples per pool). Error bars represent standard error from 2 replicate
pools. (C.) Wild-type and high pass Eednull ES cells were stained with antibodies against OCT4
and NANOG. Robust staining for is observed for both factors. Corresponding DAPI images
are found in Figure S2.
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Figure 4. Expression of downstream mediators of pluripotency
(A.) Relative expression levels for transcripts identified by Palmqvist et al.28 as being closely
correlated with functional pluripotency in low (yellow) and high (red) pass Eednull ES cells.
Most genes are expressed at wild-type levels or higher in mutant ES cells. (B.) Real-time RT-
PCR verification of selected genes represented in panel A. Real-time RT-PCR was carried out
in duplicate on RNA generated from pooled cell samples (3 different samples per pool). Error
bars for panel D represent standard error from 2 replicate pools.
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Figure 5. Chimeric contribution of Eednull ES cells
Eednull cell contribution in chimeric embryos recovered at 9.5 dpc is visualized by β-
galactosidase staining. Whole-mount embryos from chimeric embryos made with low pass
Eednull ES cells (A-C) show fairly normal development of even moderately high contribution
chimeras (A,B). Eednull cells can occasionally be seen in the embryonic forebrain and heart
field (C), although these areas were reported to be relatively devoid of mutant cells in chimeric
embryos21. Paraffin sections (D, with futher magnification in E and F) revealed that low pass
Eednull ES cells contribute to tissues derived from all three embryonic germ layers, including
neurepithelium (arrows; D, E), mesenchyme (asterisk; E,F) gut endoderm (dashed arrow; F).
Results were similar to those previously reported in21. (G-L) High pass Eednull cell
contribution in chimeric embryos recovered at 9.5 dpc is visualized by β-galactosidase staining.
Whole-mount images representing high (G) and moderate (H) contribution chimeric embryos
are shown. High contribution chimeras are almost exclusively Eednull ES cell derived, as
indicated by blue staining in the whole-mount embryo (G) and cryosections (J). As reported
previously21, high contribution chimeras suffer defects also seen in homozygous Eednull
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embryos, including an overgrown allantois (boxed area; J), poorly developed neurepithelium
(arrow; J), and severe sparsity of embryonic mesoderm (asterisk; J). Moderate range chimeras
show relatively normal development (G, I, and L), with Eednull cells contributing seamlessly
to neurepithelium (solid arrows; I, L), surface epithelium (open arrow; L), mesenchyme
(asterisk; I,L), and endoderm (dashed arrow; L). Even relatively well-differentiated cell types,
such as embryonic blood (K) can be populated by Eednull cells.
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Figure 6. Positive-only model for the maintenance of stem cell pluripotency
This cartoon demonstrates how pluripotency factors might regulate stem cell self-renewal in
the absence of repressive factors. PRC2, and perhaps other repressive factors are dispensable
for the maintenance of pluripotency in mouse ES cells.
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Table 1
Summary of blastocyst injections
Stage Total embryos Resorptions Number of chimeras
Early passage (p7) Eednull ES 9.5 dpc 15 1 6 (43%)
Late passage (p34) Eednull ES 9.5 dpc 27 2 13 (52%)
Late passage (p34) Eednull ES 10.5 dpc 11 2 3 (33%)
Late passage (p34) Eednull ES 10.5 dpc 53 17 ND
Late passage (p34) Eednull ES 12.5 dpc 7 0* 3 (43%)*
*
Total number of embryos from 3 females. Suggests that there may have been earlier resorptions.
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